TNF and rheumatoid arthritis: The majority of data from the international research shows that abatacept is both clinically efficient and highly cost effective in the treatment of moderate to severe rheumatoid arthritis, especially in patients that have demonstrated inadequate response or intolerance to anti-TNF agents or DMARDs.